AbCellera Biologics Inc. (ABCL)
NGS · Common · CUSIP 00288U106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ABCL and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
00288U106
Market Cap
Large Cap
IPO
12/11/2020 · $20.00/share
Business: AbCellera Biologics Inc. is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.

Company Contact

CEO
Carl Hansen
CFO
Andrew Booth
Headquarters
2215 Yukon Street, Vancouver, BC V5Y 0A1
Phone
604-559-9005
Investor Relations
Jessica Yingling · 236-521-6777
Email Form
Request Form »
SEC EDGAR Filings
View filings »